Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01086475 · ClinicalTrials.gov registry record · Phase 3
D-Cycloserine and Social Skills Training in Autism Spectrum Disorders
A Phase 3 study of Autistic Disorder and Asperger's Disorder, sponsored by Indiana University.
- Completed
- Registry status
- Phase 3
- Development phase
- 68
- Enrollment target
- 2
- Study locations
NCT01086475: Completed Phase 3 study of Autistic Disorder and Asperger's Disorder, sponsored by Indiana University.
NCT01086475 is a Phase 3 study of Autistic Disorder and Asperger's Disorder that has completed, run by Indiana University. The registered enrollment target is 68 participants, below the 111-participant average among 27 other Autistic Disorder trials with a reported enrollment target (39% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01086475, a Phase 3 study of Autistic Disorder and Asperger's Disorder, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 68 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to determine the effectiveness of D-cycloserine for improving social impairment in child with pervasive developmental disorders (PDD).
Primary Outcome
The 65-item SRS is a standardized measure of the core symptoms of autism. Each item is scored on a 4-point Likert scale. The score of each individual item is summed to create a total raw score. A total scores results are as follows: 0-62: Within normal limits 63-79: Mild range of impairment 80-108: Moderate range of impairment 109-149: Severe range of impairment
Conditions Studied
Interventions
- DRUG Placebo
- DRUG D-cycloserine
Study Locations (2)
Indiana
- Riley Hospital for Children - Indianapolis
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2010-03 |
| Est. Completion | 2014-01 |
| Phase | Phase 3 |
What the finished NCT01086475 record still lists
NCT01086475 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 111-participant average among 27 other Autistic Disorder trials with a reported enrollment target (39% lower).
The record links to 3 conditions, with Autistic Disorder appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01086475 reports a single indexed study location in Indiana, Ohio.
Frequently Asked Questions
What is clinical trial NCT01086475 about?
NCT01086475 is a clinical study titled "D-Cycloserine and Social Skills Training in Autism Spectrum Disorders". The purpose of this study is to determine the effectiveness of D-cycloserine for improving social impairment in child with pervasive developmental disorders (PDD).
What is the current status of trial NCT01086475?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 68 participants. The study started on 2010-03. Estimated completion is 2014-01.
What conditions does trial NCT01086475 study?
This clinical trial studies the following conditions: Autistic Disorder, Asperger's Disorder, Pervasive Developmental Disorder NOS.
What interventions are being tested in trial NCT01086475?
The interventions under investigation include: Placebo (DRUG), D-cycloserine (DRUG).
Who is sponsoring clinical trial NCT01086475?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01086475 being conducted?
This trial has 2 study locations across Indiana, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autistic Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01086475's enrollment target sits among peer trials
68 14th of 27 higher than 14 of 27 other Autistic Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autistic Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Effectiveness of Aripiprazole and D-Cycloserine to Treat Symptoms Associated With Autism
COMPLETED · Phase 3
-
Study of Fluoxetine in Autism
COMPLETED · Phase 3
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
SQUED™ Series 28.1 Home-use and Treatment of Autowave Reverberator of Autism
RECRUITING
-
Telehealth Parent-Implemented Intervention for Young Children With Autism Spectrum Disorder (ASD)
RECRUITING · NA
-
Randomized Clinical Trial of TUNE In 3.0: A Social/Emotional Program for Adults With Autism Spectrum Disorder
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia